The PennZone

  • Home
  • Books
  • Entertainment
  • Marketing
  • Non-profit
  • Music
  • Education
  • Health
  • Business

Dr. Jeff Gelblum Opens Jupiter Neurology Office with Infusion Center
The PennZone/10287893

Trending...
  • Allstream Energy Partners Nominated in Multiple Categories for Fast Company's Best Workplaces for Innovators
  • Garage door installation or repair in Minnesota? Which makes more sense for your family?
  • Congressman Chuck Edwards (NC-11) Presents ReadyCommunities Partnership 2026 National Service Award to Local Businessman / US Air Force Veteran
Jupiter Neurology and Infusion Center
Dementia Specialist, Dr. Jeffrey Gelblum, Expands the Infusion Center in his Jupiter Neurology Office.

JUPITER, Fla. - PennZone -- To accommodate the exploding need for neurology services in Palm Beach, Martin, and St. Lucie counties, Jupiter Neurologist,  Dr. Jeff Gelblum, proudly announces the expansion of his in-office infusion center located at 601 University Boulevard, Suite 102, in Jupiter, Florida.

Dr. Gelblum observes that an explosion of newly approved IV therapies for the treatment of Alzheimer's, MS, myasthenia gravis, and migraine warrant his center's increased capacity for IV treatment.

"Our Jupiter Infusion Center had been running at full capacity, and with the approval of even more disease-modifying treatments for severe neurologic conditions, we are now poised to meet the growing needs of our tri-county clientele," states Dr. Gelblum.

The infusion center accepts most insurances and eagerly welcomes referrals from all physicians and specialists in the community, including rheumatologists and other neurologists.

More on The PennZone
  • Put Your Herd on Your Phone: Kiko Nation Makes Livestock Management Simple
  • Future Intelligence Think Tank Surpasses 1,000 Members Exploring Human and Artificial Intelligence
  • Gary Bernstein Expands Media Leadership Role With Senior Strategic Advisor Appointment To Blacksun Private Equity
  • Headline: House of Nova Paints Every Face in Gold at New York Fashion Week
  • Can Government Operate Better Through Innovation?

He concludes, "Our state-of-the-art neurology practice provides this area with top-notch clinical, diagnostic, and infusion care. As our community grows, we are dedicated to fulfilling the growing expectations of our patients and colleagues."

About Jeffrey Gelblum, MD, FAAN

Dr. Jeffrey Gelblum is a board-certified neurologist with offices in Aventura and Jupiter, Florida. He has successfully treated thousands of patients over 25 years, from South Florida and worldwide. He is considered a global thought leader in the neurologic treatment of dementia, seizure disorders, Parkinson's, Diabetic and Peripheral Nerve Disorder, Covid Long-Hauler, trauma, chronic pain, and more. He has hosted educational symposia in the U.S. and overseas.

Dr. Gelblum maintains numerous research FDA-sponsored affiliations, providing patients immediate access to promising new treatment protocols. He is active in multiple community outreach programs to educate the public regarding the care and treatment of neurologic disorders.

Learn more about Dr. Gelblum at https://www.fcneurology.net/business-directory/788/jeffrey-gelblum-md/

Contact
First Choice Neurology
***@jmurrayassoc.com


Source: First Choice Neurology

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Building a Diversified Healthcare Platform as Exosome Science, Telehealth, Diagnostics & Strategic Acquisitions Converge: NexTel Medical (OTCID: MAJI)
  • Most Indiana Plane Crashes Happen Away from the State's Major Airports
  • L2 Aviation Welcomes Jason Marshall as Vice President of Sales and Business Development
  • Mom Era, Still That Girl: Family Art Tees 25% Off
  • Fashion vs. Fascism - Because Democracy Should Always Be In Style
  • Lee Gunn IV Shares Lessons From 40 Years in the Courtroom on PodNumbra Podcast
  • [New Book] "Historic Maps of Philadelphia" Available Now!
  • Michael H. Kaplan Recognized for 17 Years on PHPA Workers' Compensation Panel and Advocacy for Professional Athletes
  • International Society of Medical AI Convenes Global Faculty in Florence for ISMAI 2026
  • Boston Industrial Solutions Introduces Personalized Printing Training
  • Century Fasteners de Mexico Exhibiting at the 2026 Automotive & Aerospace Nearshoring Summit
  • Retell AI White Label Platform for Agencies Launched by VoiceAIWrapper, With Branded Client Portals and No Per-Minute Markup
  • FOCUS Names Mark Phillips Senior Vice President of Business Development
  • Notaron Expands Online Notarization Access Following Wisconsin Approval
  • Wings Air Helicopters Selected to Support VIP Transportation for Resorts World in New York
  • Scoop Social Co. Brings Its Signature Mobile Dessert Experience to Houston This October
  • The Social Capital Revolution Comes to Phoenix!
  • Lawsuit Alleges American Deli Food Caused Severe Illness, Acute Kidney Failure, And Eight-day Hospitalization
  • FBI/DoW plot uncovered to hurt Trump/Vance through encouraged "widespread" cybersecurity breaches and racketeering theft of $80m in USDA payments
  • Bettingbladet releases H1 2026 report on the Swedish online gambling market

Popular on PennZone

  • Benny Turner Revisits Freddie King's Legacy for 50th Anniversary of His Passing - 221
  • Easwe Lightweight Electric Wheelchair Collection with Travel-Focused Mobility Solutions - 196
  • Church Tradition Takes an Unexpected Turn at the Ford Community & Performing Arts Center - 189
  • Master Of Science, Juggernaut Of The Screen: Landon Brittain Emerges As Hollywood's Most Unlikely Leading Man - 182
  • 3ptechies Partners with Coolmuster to Give Away Data Recovery Software Licenses - 174
  • Black Dog Venture Partners and VC Fast Pitch to Host "San Francisco Investors and Innovators" Networking Event - 154
  • FindCostSeg Launches Nationwide Directory for Cost Segregation Providers - 147
  • GitKraken Names Jim Shaw CEO as Software Teams Move From AI Adoption to Multi-Agent Orchestration - 144
  • INAD Warriors' 4th Annual "Dancing with the INAD Stars" Gala - 141
  • Michael Fischer, President and CEO of Client 1st Financial, Named to LVB 300 - 120

Similar on PennZone

  • Warrant Activity, AVERSA™ Progress and a Potentially Transformative Fall Take Center Stage: Nutriband Inc. (N A S D A Q: NTRB)
  • Michael H. Kaplan Advocates for Seriously Injured Colorado Workers Who Need In-Home Care
  • Infinity Infusion Solutions Named Finalist for D Magazine's D CEO 2026 Excellence in Healthcare Awards
  • Building a Diversified Healthcare Platform as Exosome Science, Telehealth, Diagnostics & Strategic Acquisitions Converge: NexTel Medical (OTCID: MAJI)
  • International Society of Medical AI Convenes Global Faculty in Florence for ISMAI 2026
  • Lawsuit Alleges American Deli Food Caused Severe Illness, Acute Kidney Failure, And Eight-day Hospitalization
  • European Patent for ALS Program Expands the Story: HOPE Deploys Robotic TMS & FDA Commercialization Path Advances: NRx Pharmaceuticals: NAS DAQ: NRXP
  • Ten Ten Ten Awards Provisional Certification to Cara AI for Home-Based Health Assessments
  • IDI Consulting Partners with the American Heart Association to Advance Heart Health Awareness
  • FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us